Triple Negative Breast Neoplasms D064726

Diseases [C] » Neoplasms [C04] » Neoplasms by Site » Breast Neoplasms » Triple Negative Breast Neoplasms

Diseases [C] » Skin and Connective Tissue Diseases [C17] » Skin Diseases » Breast Diseases » Breast Neoplasms » Triple Negative Breast Neoplasms

Description

Breast neoplasms that do not express ESTROGEN RECEPTORS; PROGESTERONE RECEPTORS; and do not overexpress the NEU RECEPTOR/HER-2 PROTO-ONCOGENE PROTEIN.   MeSH

Hierarchy View


Phase 4 Indicated Drugs (2)

Other Experimental Indicated Drugs (3)


Organization Involved with Phase 4 Indications (4)

Organization Involved with Phase 2 Indications (234)

Stanford University

State University of New York, Buffalo

Susan G. Komen Breast Cancer Foundation

Sutter Health

Syndax Pharmaceuticals

Synta Pharmaceuticals Corp.

Takeda

Tapimmune Inc.

Temple University

Tennessee Oncology, PLLC

Tesaro

The Christie NHS Foundation Trust

The University of Texas, Dallas

Thomas Jefferson University

Translational Breast Cancer Research Consortium

Trans Tasman Radiation Oncology Group

Triple Negative Breast Cancer Foundation

Turnstone Biologics, Inc.

Union Therapeutics

Universidad Autonoma de Barcelona

Universidad Complutense de Madrid

Université catholique de Louvain

University Hospital of North Norway

University of Alabama, Birmingham

University of Amsterdam

University of Brescia

University of Calgary

University of California, San Francisco

University of Chicago

University of Colorado, Denver

University of Freiburg

University of Illinois at Chicago

University of Kansas

University of London

University of Manchester

University of Maryland

University of North Carolina at Chapel Hill

University of Oxford

University of Rochester

University of Southern Denmark

University of South Florida

University of Stavanger

University of Texas at Houston

University of Toronto

University of Ulsan

University of Valencia

University of Washington

University of Wisconsin

Vanderbilt University

VelosBio

Virginia Commonwealth University

Washington University in St. Louis

West Cancer Center

West German Study Group

Yale University

Yiling Pharmaceutical Inc.

Zenith Epigenetics

Organization Involved with Other Experimental Indications (3)

Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.